3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
6
Carcinoma, Renal Cell
5
Carcinoma, Transitional Cell
3
Thyroid Neoplasms
2
Prostatic Neoplasms
2
Nasopharyngeal Carcinoma
2
Myelodysplastic Syndromes
2
Leukemia, Myeloid, Acute
2
Clear-cell metastatic renal cell carcinoma
2
Vulvar Neoplasms
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Urachal adenocarcinoma
1
Triple Negative Breast Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Somatostatinoma
1
Seminoma
1
Sarcoma
1
Rectal Neoplasms
1
Rare Diseases
1
Pseudomyxoma Peritonei
1
Pheochromocytoma
1
Perivascular Epithelioid Cell Neoplasms
1
Penile Neoplasms
1
Parathyroid Neoplasms
1
Paranasal Sinus Neoplasms
1
Paraganglioma
1
Paget Disease, Extramammary
1
Interventions
Cyclophosphamide
23
fludarabine
15
fludarabine phosphate
10
Methotrexate
10
blinatumomab
9
Whole-Body Irradiation
9
Vincristine
7
Specimen Handling
7
Dexamethasone
7
merphos
6
Tacrolimus
6
Mycophenolic Acid
6
Stem Cell Transplantation
5
Peripheral Blood Stem Cell Transplantation
5
Mesna
5
Mercaptopurine
5
Melphalan
5
Leukapheresis
5
Granulocyte Colony-Stimulating Factor
5
Filgrastim
5
Cytarabine
5
Cyclosporine
5
Biopsy
5
pegaspargase
4
Prednisone
4
Magnetic Resonance Spectroscopy
4
Etoposide
4
Calcium Dobesilate
4
Busulfan
4
prednylidene
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
CTLA-4 Antigen
×
30 days
×
Clear all
No trials found.